Tech Company Financing Transactions

ZielBio Funding Round

On 9/27/2019, ZielBio received $25.1 million in Series A financing from Morningside Group, Partners Innovation Fund and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

315 Old Ivy Way 301
Charlottesville, VA 22903
USA

Phone

Undisclosed

Website

www.zielbio.com

Email Address

Not Recorded

Overview

ZielBio is an early-stage biotechnology company that identifies novel high value disease targets and develops therapeutic interventions to improve patient outcomes. Our proprietary drug discovery platform Zielfind combines the power of functional, high throughput screening with large content data analytics to identify high value targets.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Financial Officer

Colin Rolph

        

Chief Medical Officer

James O'Leary

        

Founder

Kimberly Kelly

        

VP - Bus. Development

Robert Lutz

        

VP - Operations

Anne Heldreth

        

Browse more venture capital transactions:

Prev: 9/27/2019: Mercury venture capital transaction
Next: 9/27/2019: Honeycomb venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary